lohud.com

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Acorda announces price of shares

August
7

Acorda Therapeutics Inc., the Hawthorne company that sells a drug for people with multiple sclerosis, said the 4 million shares that will be offered to the public will carry a price of $28.50 apiece. The shares are being offered by Deutsche Bank Securities Inc. as underwriter.

The company has granted the underwriter the option to buy an additional 600,000 shares at the offering price to cover any over-allotments.

Acorda, which markets Zanaflex, said it plans to use the money it makes from the offering to fund the filing of an application to sell Fampridine-SR and for the costs of marketing the drug, if it is approved. That drug is also for patients with multiple sclerosis.
The company will also use proceeds for other research and general corporate purposes.

Acorda shares were trading at $28.46 at 10:10 a.m., down $1.47.

This entry was posted on Thursday, August 7th, 2008 at 9:36 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: del.icio.us Digg | Print Print | Email Email

Advertisement

Leave a Reply

About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.

Enter your email address to get daily updates from Business in the Burbs sent to your inbox:

About the Authors

Categories

Other recent entries


Latest LoHud Business news


Links

Monthly Archives

Bad Behavior has blocked 3602 access attempts in the last 7 days.